Skip to main content
TipRanks
Go Ultimate75% OFF

Bachem Holding AG (BCHMF) Stock Price & Analysis

0 Followers

BCHMF Stock Chart & Stats

$94.81-$1.57(-1.63%)
At close: 4:00 PM EST
$88$89$90$91May 4Jun 4Aug 4
Day’s Range
$92.71 - $96.90
52-Week Range
$58.30 - $108.92
Previous Close
$96.38
Volume
N/A
Average Volume (3M)
0
Market Cap
$7.11B
Enterprise Value
$5.83B
Total Cash (Recent Filing)
$51.57M
Total Debt (Recent Filing)
$208.10M
Price to Earnings (P/E)
40.0
Beta
1.18
Next Earnings
Mar 04, 2027 (Est.)
Dividend Yield
0.61%

Bulls Say, Bears Say

Bulls Say

Very Low Leverage

The exceptionally conservative capital structure reduces financial strain and preserves flexibility for capacity investment, customer programs, or downturns. A large and growing equity base also supports resilience because profitability is not dependent on heavy borrowing or leverage.

Resilient Profitability And Revenue Growth

Steady multi-year revenue expansion and solid profitability indicate durable demand for Bachem’s peptide and oligonucleotide manufacturing capabilities. This earnings base can support continued investment and customer support while providing operating resilience across development and commercial projects.

Specialized Peptide And Oligonucleotide CDMO Position

Bachem’s specialized CDMO model serves customers across drug discovery, clinical development, and commercial-scale production. Supporting complex, regulated therapeutics can deepen customer relationships and create opportunities for recurring manufacturing demand as successful programs advance.

Bears Say

Persistent Negative Free Cash Flow

Repeated negative free cash flow means substantial investment spending or working-capital needs are absorbing internally generated cash. If this pattern persists, Bachem may have less flexibility to fund expansion, dividends, or other strategic priorities without relying on external financing.

Gradual Margin Compression

Although current margins remain healthy, the downward trend suggests that cost growth, business mix, or investment requirements are taking a larger share of revenue. Continued compression could reduce the earnings benefit of future sales growth and weaken operating leverage over time.

Recent Debt Increase

The 2025 increase in total debt is notable against Bachem’s previously near-zero leverage profile. While leverage remains very low, a continued buildup would gradually reduce balance-sheet conservatism and could add financing costs or constrain future capital allocation.

Bachem Holding AG News

BCHMF FAQ

What was Bachem Holding AG’s price range in the past 12 months?
Bachem Holding AG lowest stock price was $58.30 and its highest was $108.92 in the past 12 months.
What is Bachem Holding AG’s market cap?
Bachem Holding AG’s market cap is $7.11B.
When is Bachem Holding AG’s upcoming earnings report date?
Bachem Holding AG’s next earnings report is estimated for Mar 04, 2027 (not yet confirmed), which is in 109 days.
How were Bachem Holding AG’s earnings last quarter?
Bachem Holding AG released its earnings results on Jul 30, 2026. The company reported $0.805 earnings per share for the quarter, beating the consensus estimate of $0.562 by $0.243.
Is Bachem Holding AG overvalued?
According to Wall Street analysts Bachem Holding AG’s price is currently Undervalued.
Does Bachem Holding AG pay dividends?
Bachem Holding AG pays an annual dividend of $0.574 which represents an annual dividend yield of 0.61%. See more information on Bachem Holding AG dividends here
What is Bachem Holding AG’s EPS estimate?
Bachem Holding AG’s EPS estimate is 1.89.
What happened to Bachem Holding AG’s price movement after its last earnings report?
Bachem Holding AG reported an EPS of $0.805 in its last earnings report, beating expectations of $0.562. Following the earnings report the stock price went up 7.038%.
Which hedge fund is a major shareholder of Bachem Holding AG?
Currently, no hedge funds are holding shares in BCHMF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology